{"id":125810,"date":"2022-05-20T14:41:19","date_gmt":"2022-05-20T14:41:19","guid":{"rendered":"https:\/\/ccs.ca\/?page_id=125810"},"modified":"2024-05-14T11:45:22","modified_gmt":"2024-05-14T15:45:22","slug":"hls-atherosclerosis-recipients","status":"publish","type":"page","link":"https:\/\/ccs.ca\/hls-atherosclerosis-recipients\/","title":{"rendered":"CCS\/HLS Atherosclerosis Research Award Recipients"},"content":{"rendered":"\n
<\/div>\n\n\n\n
2022<\/mark><\/h3>\n\n\n\n
Principle Investigator<\/th>
Proposal Title<\/th>
Award Amount<\/th><\/tr><\/thead>
Mark Chandy<\/strong> <\/td>
Investigating the Safety and Efficacy of the Novel Cannabinoid Receptor 1 (CB1) Antagonist, Genistein for Attenuating Adverse Cardiovascular Events<\/td>
2022 Principle Investigator Proposal Title Award Amount Mark Chandy Investigating the Safety and Efficacy of the Novel Cannabinoid Receptor 1 (CB1) Antagonist, Genistein for Attenuating Adverse Cardiovascular Events $35,000 2021 Principle Investigators Proposal Titles Award Amounts Nadia Bouabdallaoui Impacts of Colchicine on Coronary Microvascular Dysfunction in Men and Women with Heart Failure and Preserved Ejection […]<\/p>\n","protected":false},"author":7813,"featured_media":0,"parent":0,"menu_order":99,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"om_disable_all_campaigns":false,"footnotes":""},"wf_page_folders":[181],"acf":[],"yoast_head":"\n
CCS\/HLS Atherosclerosis Research Award Recipients - Canadian Cardiovascular Society<\/title>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\t\n